Gene redundancy and pharmacological gene therapy: Implications for X-linked adrenoleukodystrophy
- 1 November 1998
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 4 (11) , 1261-1268
- https://doi.org/10.1038/3242
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Evolutionary origins and maintenance of redundant gene expression during metazoan developmentTrends in Genetics, 1997
- Muscular Dystrophy: Backup Gene May Help Muscles Help ThemselvesScience, 1997
- Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgeneNature, 1996
- Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrateBlood, 1994
- Thinking about genetic redundancyTrends in Genetics, 1993
- A Short-Term Trial of Butyrate to Stimulate Fetal-Globin-Gene Expression in the β-Globin DisordersNew England Journal of Medicine, 1993
- Adrenoleukodystrophy: Impaired oxidation of fatty acids due to peroxisomal lignoceroyl-CoA ligase deficiencyArchives of Biochemistry and Biophysics, 1989
- Direct demonstration that the deficient oxidation of very long chain fatty acids in X-linked adrenoleukodystrophy is due to an impaired ability of peroxisomes to activate very long chain fatty acidsBiochemical and Biophysical Research Communications, 1988
- Hydroxyurea induction of hemoglobin F production in sickle cell disease: relationship between cytotoxicity and F cell productionBlood, 1986
- Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex.Proceedings of the National Academy of Sciences, 1983